We are live on ! Find out more
LAB icon

Standard BioTools
LAB

145 hedge funds and large institutions have $719M invested in Standard BioTools in 2024 Q1 according to their latest regulatory filings, with 72 funds opening new positions, 47 increasing their positions, 13 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

311,000% more call options, than puts

Call options by funds: $3.11M | Put options by funds: $1K

519% more capital invested

Capital invested by funds: $116M → $719M (+$603M)

454% more first-time investments, than exits

New positions opened: 72 | Existing positions closed: 13

262% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 13

100% more funds holding in top 10

Funds holding in top 10: 2 → 4 (+2)

69% more funds holding

Funds holding: 86 → 145 (+59)

25.84% more ownership

Funds ownership: 65.62% → 91.46% (+26%)

Holders
145
Holders Change
+59
Holders Change %
+68.6%
% of All Funds
2.09%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
72
Increased
47
Reduced
13
Closed
13
Calls
$3.11M
Puts
$1K
Net Calls
+$3.11M
Net Calls Change
+$3.08M

Top Buyers

1
CC
Casdin Capital
New York
+$147M
2
Viking Global Investors
Viking Global Investors
Connecticut
+$142M
3
AIM
ARK Investment Management
Florida
+$31.5M
4
Millennium Management
Millennium Management
New York
+$31.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$21.5M

Top Sellers

1
CP
Caligan Partners
New York
-$15.6M
2
HBWM
Hollow Brook Wealth Management
New York
-$4.14M
3
BFM
Boothbay Fund Management
New York
-$1.15M
4
Morgan Stanley
Morgan Stanley
New York
-$578K
5
HI
HBK Investments
Texas
-$333K
Name Holding Trade Value Shares
Change 		Change in
Stake
Dimensional Fund Advisors
26
Dimensional Fund Advisors
Texas
$3.43M +$3.06M +1,266,859 New
Renaissance Technologies
27
Renaissance Technologies
New York
$3.4M +$517K +214,258 +21%
SSA
28
Schonfeld Strategic Advisors
New York
$3.33M +$2.51M +1,038,004 +543%
NIM
29
Needham Investment Management
New York
$3.05M – – –
JCP
30
Jennifer C. Price
$2.66M – – –
GS
31
Gagnon Securities
New York
$2.32M +$2.06M +855,145 New
Northern Trust
32
Northern Trust
Illinois
$2.13M +$1.41M +583,830 +290%
MC
33
Meteora Capital
Florida
$1.83M +$1.63M +677,100 New
Citigroup
34
Citigroup
New York
$1.83M +$851K +352,604 +109%
GA
35
Gagnon Advisors
New York
$1.82M +$1.62M +672,294 New
Two Sigma Investments
36
Two Sigma Investments
New York
$1.75M +$1.18M +490,337 +313%
Bank of America
37
Bank of America
North Carolina
$1.72M +$1.34M +554,781 +680%
JP Morgan Chase
38
JP Morgan Chase
New York
$1.61M +$1.08M +448,270 +310%
Assenagon Asset Management
39
Assenagon Asset Management
Luxembourg
$1.57M +$1.24M +512,937 +783%
PCMI
40
Paradigm Capital Management Inc
New York
$1.49M +$1.21M +500,000 +1,000%
HF
41
HRT Financial
New York
$1.38M +$1.22M +507,417 New
ZDA
42
Zweig-DiMenna Associates
New York
$1.37M +$1.22M +505,535 New
UBS Group
43
UBS Group
Switzerland
$1.31M +$1.12M +462,722 +2,180%
BCPWM
44
Bradley & Co Private Wealth Management
Florida
$1.21M +$961K +397,877 +796%
RC
45
RBF Capital
California
$1.2M +$1.07M +441,572 New
CSS
46
Cubist Systematic Strategies
Connecticut
$1.2M +$999K +413,922 +1,516%
Swiss National Bank
47
Swiss National Bank
Switzerland
$1.16M +$1.03M +428,660 New
Allianz Asset Management
48
Allianz Asset Management
Germany
$1.16M +$1.03M +426,200 New
IP
49
Intellectus Partners
California
$1.15M +$871K +360,750 +575%
RG
50
Redmile Group
California
$1.12M +$994K +411,631 New
1
2
3 4 5

LAB Hedge Fund Activity: Q1 2024 in Review

145 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Standard BioTools (LAB) for Q1 2024, worth a combined $719M — up 519% from $116M a quarter earlier.

Buyers outnumbered sellers: 72 funds opened new LAB positions and 13 closed out — a net gain of 59 holders — while 47 added to existing stakes and 13 trimmed.

The largest buyer was Casdin Capital, adding an estimated $147M. The largest seller was Caligan Partners, exiting entirely with an estimated $15.6M sold.

  • 145 institutional investors held Standard BioTools (LAB) as of Q1 2024, up from 86 in Q4 2023.
  • Funds reported $719M of Standard BioTools stock for Q1 2024, up 519% quarter-over-quarter.
  • 72 funds opened new Standard BioTools positions in Q1 2024 and 13 closed out, a net change of +59 holders.
  • The largest Standard BioTools buyer in Q1 2024 was Casdin Capital, an estimated $147M added.
  • The largest Standard BioTools seller in Q1 2024 was Caligan Partners, an estimated $15.6M sold.

Based on aggregated 13F filings for Q1 2024.